This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Brain, unspecified
CD2_BENIGN_BRAIN_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D33
- Name in latin
- Neoplasma benignum cerebri non specificatum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Brain, unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Brain, unspecified
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 219 | 137 | 82 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | 41.78 | 41.18 | 42.78 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 203
- Matched controls
- 2028
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
+∞
104.4
91
*
22500
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
72.3
65
*
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
57.0
52
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
15.1
39.8
70
68
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
89.8
34.1
37
5
2152
FHL
Extraction, big brain
395.5
34.0
33
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
17.1
33.1
54
42
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
52.5
29.8
35
8
H02AB02
ATC
dexamethasone; systemic
90.6
28.7
31
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
35.5
25.9
33
11
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
64.4
20.4
23
*
N03AF01
ATC
carbamazepine; oral, rectal
10.6
20.1
40
46
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
208.4
18.9
19
*
N03AF02
ATC
oxcarbazepine; oral
17.8
18.1
28
18
130
Kela drug reimbursment
Malignant tumour
+∞
18.0
17
*
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
16.9
16
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
18.3
15.2
23
14
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
61.4
15.0
17
*
E23.00
ICD-10 Finland
Panhypopituitarism
86.5
14.8
16
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
57.5
14.0
16
*
N03AB02
ATC
phenytoin; systemic
17.8
13.8
21
13
D33.30
ICD-10 Finland
Acoustic neuroma
80.7
13.8
15
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
20.0
13.7
20
11
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
16.6
13.4
21
14
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
12.6
12
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
11.6
12.6
23
22
N03AX14
ATC
levetiracetam; systemic
19.6
12.3
18
10
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
24.6
11.8
16
7
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.1
11.7
38
87
22520
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
11.6
11
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
10.5
11.1
21
22
H02AB09
ATC
hydrocortisone; systemic
14.0
10.9
18
14
XCK00
NOMESCO Finland
Perimetry
5.6
10.6
31
63
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
115.7
10.5
11
*
23810
ICD-8 Finland
Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain
+∞
10.5
10
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
9.4
9
*
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
+∞
9.4
9
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
52.3
8.8
10
*
WF002
NOMESCO Finland
Radical radiotherapy
93.7
8.5
9
*
2151
FHL
Resection, big brain
+∞
8.4
8
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
8.4
8
*
H53.4
ICD-10 Finland
Visual field defects
8.0
7.9
17
23
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
46.8
7.8
9
*
G93.0
ICD-10 Finland
Cerebral cysts
83.0
7.5
8
*
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
83.0
7.5
8
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.1
7.3
28
76
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
+∞
7.3
7
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
7.3
7
*
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
+∞
7.3
7
*
WF099
NOMESCO Finland
Other radiotherapy
+∞
7.3
7
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.3
7.0
38
134
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
6.8
53
239
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
17.4
6.8
10
6
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
41.5
6.8
8
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.8
6.8
45
185
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
9.2
6.7
13
15
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
14.9
6.5
10
7
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
14.9
6.5
10
7
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
72.0
6.5
7
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
72.0
6.5
7
*
AA1AD
NOMESCO Finland
CT of head and brain
2.5
6.4
59
290
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.5
6.3
29
93
L01AX03
ATC
temozolomide; systemic
+∞
6.3
6
*
9161/1-C71.6
ICD-O-3
Hemangioblastoma of cerebellum, NOS
+∞
6.3
6
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
6.3
6
*
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
+∞
6.3
6
*
102
Kela drug reimbursment
Diabetes insipidus
+∞
6.3
6
*
H47.2
ICD-10 Finland
Optic atrophy
27.6
6.3
8
*
R51.80
ICD-10 Finland
Headache
2.7
6.1
42
177
G51.0
ICD-10 Finland
Bell palsy
10.5
6.1
11
11
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.1
6.0
33
118
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
23
42
6.00
12.40
1.2
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
15
7.67
7.62
1.5
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
17
6.76
6.84
1.5
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
115
756
2.10
6.72
7.0
6.0
mmol/l
1.2
1.2
0.00
103
652
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
104
684
1.99
5.83
6.2
5.5
mmol/l
1.2
1.2
0.26
99
613
(3002256) Pathology report gross observation
31
124
2.75
5.67
1.5
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
15
38
4.16
5.54
1.3
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
133
970
1.95
5.34
5.2
4.5
mmol/l
6.5
6.7
0.45
128
893
(40768804) Tissue Pathology biopsy report
87
556
1.94
5.15
2.4
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
35
158
2.45
5.02
8.5
9.3
mmol/l
2.1
1.3
0.84
27
128
(3023368) Bacteria identified in Blood by Culture
64
384
1.94
4.47
3.8
4.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
71
460
1.80
3.84
2.2
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
98
702
1.72
3.71
3.6
3.7
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
22
92
2.55
3.70
4.9
8.1
%
1.3
1.5
0.61
22
92
(3035637) Corticotropin [Mass/volume] in Plasma
8
13
6.34
3.53
1.4
1.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
20
83
2.55
3.42
4.9
6.1
mmol/l
24.1
24.6
0.33
20
83
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
21
91
2.45
3.29
5.1
8.1
%
0.7
0.7
0.02
21
91
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
7
8.77
3.28
1.0
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
15
5.49
3.22
1.3
1.2
nmol/l
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
20
4.64
3.15
2.7
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
67
451
1.70
3.09
3.6
3.0
ph
7.4
7.4
0.10
12
71
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
40
242
1.80
2.65
1.7
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
70
494
1.61
2.64
3.4
3.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
25
3.71
2.60
1.4
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
23
116
2.10
2.57
5.2
7.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
16
4.48
2.49
1.3
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
30
169
1.90
2.48
1.7
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
53
356
1.64
2.42
2.1
2.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
6
12
5.11
2.42
1.3
1.4
mmol/l
2.3
1.9
—
6
12
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
17
4.22
2.38
1.0
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
20
99
2.12
2.34
2.0
2.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
82
615
1.53
2.34
7.0
7.7
inr
1.2
1.2
0.26
23
164
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
121
2.01
2.31
2.3
1.8
ml/min/173m2
65.0
66.8
—
10
46
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
18
3.98
2.27
1.1
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
47
311
1.65
2.27
1.8
1.7
nmol/l
1439.3
1184.4
0.84
38
241
(3006315) Basophils [#/volume] in Blood
105
842
1.47
2.12
7.3
5.5
e9/l
0.0
0.0
0.46
91
720
(3019198) Lymphocytes [#/volume] in Blood
106
852
1.47
2.11
7.3
5.5
e9/l
1.8
1.9
0.89
94
741
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
25
3.28
2.11
1.1
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
104
834
1.47
2.09
7.3
5.5
e9/l
0.6
0.6
1.83
90
716
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
10
5.09
2.08
1.4
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
20
3.58
2.07
1.6
1.2
—
—
—
0
0
(3020891) Body temperature
14
63
2.31
2.05
5.1
3.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
14
63
2.31
2.05
13.7
15.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
187
0.41
2.05
1.9
1.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
26
3.15
2.03
1.1
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
21
3.41
1.98
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
55
393
1.53
1.92
6.8
5.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
21
115
1.91
1.90
3.7
3.6
ng/l
79.0
81.0
0.07
21
100
(3013115) Eosinophils [#/volume] in Blood
106
867
1.43
1.86
7.5
5.9
e9/l
0.2
0.2
0.20
92
749
(3017181) Myelocytes/100 leukocytes in Blood
20
109
1.92
1.84
2.8
4.8
%
1.8
0.9
—
6
25
(3016038) Potassium [Moles/volume] in Urine
5
12
4.24
1.83
1.4
1.0
mmol/l
42.8
37.6
—
5
12
(3049717) Cytology report of Urine Cyto stain
10
41
2.51
1.78
2.1
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
28
172
1.72
1.78
1.7
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
208
0.46
1.67
1.9
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
45
317
1.53
1.67
2.4
2.4
mosm/kgh2o
537.5
548.7
0.10
35
260
(3013650) Neutrophils [#/volume] in Blood by Automated count
111
928
1.40
1.66
9.3
6.8
e9/l
4.4
4.1
0.46
98
794
(3012095) Magnesium [Moles/volume] in Serum or Plasma
34
225
1.61
1.64
3.0
3.7
mmol/l
0.8
0.8
0.41
34
207
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
16
84
1.98
1.64
2.4
4.1
mmol/l
0.9
1.6
—
6
62
(3022096) Basophils/100 leukocytes in Blood
93
756
1.40
1.64
7.4
5.8
%
0.7
0.7
0.01
86
686
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
43
2.39
1.63
1.0
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
64
2.10
1.57
3.2
4.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
97
799
1.38
1.56
7.7
5.8
%
26.9
28.2
0.54
91
730
(3019069) Monocytes/100 leukocytes in Blood
96
790
1.38
1.55
8.1
6.0
%
9.2
8.5
1.25
89
726
(1761868) Lipid panel - Serum or Plasma
49
650
0.68
1.55
2.8
2.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
15
3.39
1.53
1.0
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
58
438
1.44
1.53
5.7
3.8
estimate
0.0
0.0
0.00
11
144
(3006504) Eosinophils/100 leukocytes in Blood
95
785
1.37
1.48
7.7
5.7
%
2.9
3.0
0.03
87
715
(3019060) Gas panel - Arterial blood
17
95
1.86
1.48
12.5
8.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
27
175
1.62
1.43
1.4
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
68
535
1.39
1.42
8.2
5.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
85
695
1.36
1.40
3.1
2.3
nmol/l
78.3
76.0
0.29
80
610
(3000850) Epithelial cells [#/volume] in Urine
46
338
1.46
1.39
2.7
2.3
e6/l
8.7
6.0
0.55
39
291
(3018010) Neutrophils/100 leukocytes in Blood
96
801
1.35
1.39
7.3
5.5
%
57.3
57.2
0.04
90
736
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
150
1341
1.38
1.38
5.4
3.9
pmol/l
14.8
14.7
0.30
138
1213
(3019150) Specific gravity of Urine by Refractometry
53
401
1.42
1.38
5.5
3.7
kg/l
1.0
1.0
0.05
13
52
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
185
1716
1.50
1.37
16.8
12.2
mg/l
25.3
20.8
0.86
153
1295
(3007164) IgA [Mass/volume] in Serum or Plasma
25
372
0.63
1.37
1.4
1.3
g/l
2.1
2.4
0.93
17
207
(3052851) Hemolysis interference index of Serum or Plasma
10
47
2.18
1.36
1.6
3.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
21
129
1.69
1.36
1.9
2.5
e9/l
66.9
65.3
0.06
16
100
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
42
2.19
1.35
1.2
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
34
2.40
1.30
1.6
3.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
18
2.82
1.29
1.6
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
25
2.44
1.25
1.5
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
80
658
1.34
1.25
3.6
3.6
ng/l
20.3
39.8
1.99
60
446
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
19
2.67
1.22
1.0
1.3
—
—
—
0
0
(3012544) pH of Venous blood
24
158
1.58
1.21
3.0
3.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
66
530
1.35
1.20
3.5
2.3
u/l
56.3
55.1
0.12
60
491
(3021440) Promyelocytes/100 leukocytes in Blood
17
102
1.72
1.20
2.5
5.0
%
0.2
0.1
—
5
22
(40761535) Cells panel - Urine sediment
21
137
1.59
1.10
3.4
3.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
21
2.41
1.09
1.4
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
21
2.41
1.09
5.8
3.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
189
1780
1.45
1.09
20.2
14.1
mmol/l
139.3
139.8
1.39
184
1730
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
51
400
1.36
1.07
1.8
2.1
mg/l
3.3
3.0
0.25
41
342
(3013512) EKG study
60
484
1.33
1.05
4.6
3.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
26
181
1.50
1.04
1.2
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
157
0.56
1.03
1.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
45
349
1.36
1.02
1.7
1.7
pmol/l
462.4
453.5
0.09
34
295
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
23
2.20
0.98
1.2
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
189
1789
1.41
0.96
19.9
14.2
mmol/l
4.0
4.0
0.34
184
1737
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
29
211
1.43
0.94
5.1
4.6
%
34.0
32.1
0.40
23
135
(3002582) Erythrocytes [#/volume] in Urine
60
494
1.30
0.91
3.4
2.8
e6/l
22.1
178.3
0.61
47
369
(3026493) Urate [Moles/volume] in Serum or Plasma
35
451
0.73
0.90
1.9
2.4
umol/l
331.0
5856.4
1.76
29
393
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
29
2.10
0.90
1.0
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
25
179
1.45
0.89
4.5
5.4
mmol/l
1.0
1.0
0.00
25
156
(3024354) Oxygen [Partial pressure] in Venous blood
18
121
1.53
0.86
2.8
2.8
kpa
4.1
4.6
0.87
18
116
(3037467) Urinalysis macro (dipstick) panel - Urine
128
1161
1.25
0.85
5.8
4.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
69
586
1.26
0.81
3.5
2.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
26
0.00
0.79
0.0
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
26
193
1.39
0.77
2.0
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
10
59
1.73
0.77
1.2
2.2
g/l
1.6
1.5
—
10
52
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
24
2.11
0.75
1.4
2.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
48
395
1.28
0.73
5.8
3.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
11
68
1.65
0.73
2.2
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
25
2.02
0.73
1.0
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
137
1264
1.22
0.72
8.2
5.5
u/l
76.7
75.6
0.12
131
1168
(36304419) Bacteria [Presence] in Urine
53
443
1.26
0.71
3.5
2.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
15
102
1.51
0.69
1.1
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
95
849
1.21
0.68
4.9
3.5
estimate
0.0
0.0
0.00
13
149
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
86
1.54
0.67
1.9
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
83
733
1.21
0.67
10.1
7.9
e9/l
0.0
0.0
0.50
64
581
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
29
1.74
0.64
1.0
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
77
679
1.21
0.63
5.1
3.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
137
0.64
0.63
1.2
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
28
219
1.32
0.62
2.1
2.3
g/l
2.2
2.3
0.94
28
207
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
57
489
1.22
0.61
2.6
3.0
ng/l
1093.3
1436.6
0.48
50
397
(1002224) Polysomnography panel
12
80
1.53
0.61
1.2
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
6
35
1.73
0.58
3.3
1.7
pmol/l
134.3
240.1
—
6
30
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
160
0.67
0.58
1.3
1.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
8
55
1.47
0.56
5.0
1.7
ug/l
4.5
2.3
—
8
46
(3003694) ABO and Rh group [Type] in Blood
50
427
1.22
0.56
1.3
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
336
0.78
0.56
1.3
1.3
iu/ml
74.1
40.3
—
10
113
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
205
1.30
0.55
11.4
6.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
94
855
1.17
0.53
6.1
4.8
estimate
0.0
0.0
0.00
13
143
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
63
1.45
0.53
1.4
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
15
109
1.40
0.52
2.4
2.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
27
332
0.79
0.51
1.4
1.3
u/ml
16.4
14.3
0.06
12
137
(3009261) Glucose [Presence] in Urine by Test strip
95
867
1.17
0.51
4.9
3.5
estimate
0.0
0.0
0.00
13
146
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
109
0.63
0.50
1.0
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
33
274
1.24
0.48
3.1
2.5
e6/l
0.3
1.2
3.43
16
148
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
47
1.51
0.48
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
166
1727
0.84
0.48
4.8
4.4
mmol/l
1.5
1.5
0.01
159
1602
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
167
1736
0.84
0.47
4.7
4.4
mmol/l
4.7
4.7
0.17
157
1620
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
171
1772
0.84
0.45
5.1
4.9
mmol/l
2.8
2.8
0.01
158
1645
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
13
95
1.39
0.45
2.0
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
28
231
1.24
0.44
1.2
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
56
1.44
0.43
1.3
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
13
96
1.38
0.42
1.3
1.2
—
—
—
0
0
(3019225) pH of Specimen
19
150
1.29
0.42
2.8
3.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
33
1.53
0.41
2.6
1.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
187
1.26
0.41
1.7
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
60
1.35
0.40
1.5
1.7
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
161
1670
0.86
0.39
4.3
4.0
mmol/l
1.3
1.3
0.42
154
1536
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
36
1.40
0.38
1.0
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
5
78
0.63
0.36
2.4
1.9
mg/l
5.0
3.6
—
5
63
(40760892) CBC W Ordered Manual Differential panel - Blood
43
379
1.17
0.36
4.4
4.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
24
201
1.22
0.34
3.0
2.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
13
165
0.77
0.33
1.4
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
169
1636
1.14
0.33
14.3
10.4
ml/min/173m2
84.4
81.4
0.99
142
1302
(40768797) Stomach Pathology biopsy report
20
239
0.82
0.31
1.5
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
99
0.70
0.31
1.4
2.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
123
1288
0.90
0.31
4.9
4.2
mm/h
12.0
11.6
0.13
117
1179
(3000492) Spirometry study
19
157
1.23
0.30
1.8
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
64
588
1.12
0.30
4.2
3.4
e6/l
20.7
117.4
2.97
50
402
(3015736) pH of Urine
74
686
1.12
0.30
5.0
3.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
167
1.22
0.29
1.2
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
62
1.30
0.28
2.8
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
41
369
1.14
0.27
1.7
1.8
mg/l
1.3
1.0
0.29
25
284
(4034850)
8
67
1.20
0.26
12.0
9.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
72
0.69
0.26
1.6
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
74
0.67
0.26
3.4
2.0
—
—
—
0
0
(4010399)
15
124
1.23
0.24
1.9
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
83
0.72
0.24
1.3
1.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
50
459
1.12
0.24
3.8
2.7
e6/l
0.4
0.3
0.10
38
328
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
29
257
1.15
0.23
3.2
2.7
e6/l
1.9
3.5
0.57
12
131
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
40
1.26
0.22
1.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
9.4
—
0
10
(3011648) Oxygen content in Venous blood
0
10
0.00
0.21
0.0
1.8
—
13.2
—
0
10
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
119.3
—
0
12
(3029075) Extractable nuclear Ab panel - Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
13
0.00
0.21
0.0
1.2
—
756642.6
—
0
7
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
35
320
1.11
0.18
1.2
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
166
1694
0.92
0.18
4.8
4.5
mmol/l
5.7
6.0
2.10
156
1541
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
63
1.11
0.17
1.9
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
92
1.21
0.16
3.6
3.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
92
1.21
0.16
1.1
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
39
417
0.92
0.14
1.3
1.3
u/ml
0.9
1.7
0.67
14
109
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
277
1.10
0.13
1.7
1.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
85
1.18
0.12
2.9
2.0
%
1.5
1.2
—
10
85
(3002385) Erythrocyte distribution width [Ratio]
144
1413
1.06
0.11
18.4
14.8
%
13.7
13.6
0.46
137
1382
(3009508) Creatinine [Moles/volume] in Urine
51
533
0.94
0.10
2.9
3.1
mmol/l
7.4
7.6
0.10
44
452
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
45
1.11
0.10
1.6
2.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
45
1.11
0.10
1.2
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
11
124
0.88
0.09
5.4
3.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
156
1582
0.95
0.09
17.1
13.4
%
39.7
40.7
0.77
103
1190
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
13
144
0.90
0.08
2.7
3.9
ng/l
71.5
210.6
2.95
13
130
(3020682) Albumin/Creatinine [Ratio] in Urine
50
520
0.95
0.08
3.3
4.1
mg/mmol
4.1
7.9
0.92
31
322
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
58
1.04
0.08
1.5
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
61
0.82
0.08
1.0
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
62
0.80
0.08
1.0
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
62
0.80
0.08
1.0
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
195
1934
1.08
0.08
24.8
17.7
e9/l
255.9
251.7
0.41
190
1885
(3041096) Erythrocytes [Presence] in Urine by Automated
47
489
0.95
0.08
3.6
3.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
195
1935
1.07
0.07
24.8
17.7
e12/l
4.4
4.5
1.59
189
1873
(3010813) Leukocytes [#/volume] in Blood
195
1935
1.07
0.07
24.8
17.7
e9/l
6.6
6.6
0.06
190
1876
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
83
0.84
0.07
1.3
1.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
78
761
1.04
0.07
2.7
2.6
ug/l
125.7
94.3
1.04
70
704
(40761511) CBC panel - Blood by Automated count
183
1816
1.05
0.05
15.7
11.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
27
258
1.05
0.05
3.4
2.4
ug/l
0.8
0.7
0.01
21
149
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
47
457
1.04
0.04
1.7
1.7
mmol/l
1.9
1.4
1.68
42
390
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
37
358
1.04
0.04
4.6
3.4
%
22.4
24.3
0.36
19
148
(46235355) HIV 1 and 2 tests - Meaningful Use set
30
289
1.04
0.04
1.4
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
10
109
0.91
0.04
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
186
1849
1.04
0.04
11.8
8.8
u/l
26.0
25.9
0.03
178
1783
(21494755) Public health laboratory ask at order entry panel
19
181
1.05
0.03
1.3
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
108
0.92
0.03
1.0
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
36
352
1.03
0.02
3.0
4.1
ng/l
17.0
220.7
1.58
29
269
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
163
1622
1.02
0.01
5.7
4.7
mu/l
1.6
1.9
2.57
148
1473
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
146
0.96
0.00
2.4
2.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
50
494
1.02
0.00
2.9
3.2
mg/l
27.1
187.2
0.64
31
308
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
70
699
1.00
0.00
2.3
2.0
pmol/l
95.3
97.0
0.12
42
356
(3044889) 12 lead EKG panel
118
1179
1.00
0.00
3.8
3.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
162
1617
1.01
0.00
5.7
5.9
mmol/mol
39.5
39.9
0.23
151
1518
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
110
1103
0.99
0.00
2.6
3.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
116
1155
1.01
0.00
5.3
3.1
u/l
58.7
44.4
1.14
110
1080
(3019832) Treponema pallidum Ab [Presence] in Serum
15
155
0.97
0.00
1.3
1.5
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
5
56
0.89
0.00
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
56
0.89
0.00
1.2
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
3.5
—
0
7
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
62
0.97
0.00
1.0
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
62
0.97
0.00
1.0
1.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
5
0.00
0.00
0.0
2.6
—
0.1
—
0
5
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
49
1.02
0.00
2.8
3.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
14.8
—
0
5
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
65
0.92
0.00
1.8
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
3.2
—
102.4
—
0
5
(4211845)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
22.2
—
0
6
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
5.5
—
91.3
—
0
6
(42529406) Shigella sp [Presence] in Stool by Culture
5
57
0.87
0.00
1.2
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
89
0.90
0.00
1.5
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
99
0.91
0.00
1.2
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
55
0.91
0.00
1.2
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
1553.1
—
0
7
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
5
51
0.98
0.00
2.0
1.7
—
0.1
—
0
9
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BRAIN_NOS_EXALLC – Benign neoplasm: Brain, unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).